...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Should we expect a synopsis from yesterday’s AGM?

Heard from someone who was there. Pretty much a rubber stamp event - no NR came out so nothing material for sure came out.

Best hope for short term imo is maybe they are in blaclout period & working out details of a deal & this is the last AGM we every see!

got a mail into Chris asking where the video or whatever it is that was going to be put up following the AGM??? 

Share
New Message
Please login to post a reply